Piramal Pharma Limited has informed the Exchange about Schedule of meet
PPLPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Piramal Pharma Limited has informed the stock exchanges about a conference call scheduled with investors and analysts on 29th July 2025, from 9:30 AM to 10:15 AM IST. The purpose of the call is to discuss the company's Q1FY2026 financial results. Dial-in details have been provided for participants from India, USA, UK, Singapore, and Hong Kong, along with a Diamond Pass option for prior registration. The intimation has been made under Regulation 30(6) of SEBI Listing Regulations.
This is a routine regulatory disclosure ahead of the company's Q1FY26 earnings call. Investors should listen for updates on revenue growth, margin trends, and business outlook across Piramal Pharma's segments (Pharma Solutions, Critical Care, and Consumer Healthcare). The announcement itself is unlikely to move the stock price materially, but management commentary during the call could shape near-term sentiment.